Drug Profile
Research programme: vitamin D analogues - Deltanoid Pharmaceuticals
Alternative Names: 2MBisP; DP-006Latest Information Update: 28 Nov 2019
Price :
$50
*
At a glance
- Originator University of Wisconsin-Madison
- Developer Deltanoid Pharmaceuticals
- Class Small molecules; Vitamin D analogues
- Mechanism of Action Calcitriol receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Acne
Most Recent Events
- 28 Nov 2019 No recent reports of development identified for preclinical development in Acne in USA
- 20 Oct 2015 Preclinical trials in Acne in USA (unspecified route)